← Back to Search

Strict blood pressure control for Chronic Kidney Disease (PERFORMANCE Trial)

N/A
Waitlist Available
Led By Raymond Hsu, MD MAS
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up months 4-12 and study end
Awards & highlights

PERFORMANCE Trial Summary

This study is evaluating whether intensive blood pressure lowering may help reduce the risk of progression to end-stage renal disease.

Eligible Conditions
  • Chronic Kidney Disease
  • High Blood Pressure

PERFORMANCE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~months 4-12 and study end
This trial's timeline: 3 weeks for screening, Varies for treatment, and months 4-12 and study end for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Achieved Blood Pressure
End-stage Renal Disease
Falls and syncope by self-report or based on emergency room visits
+1 more
Secondary outcome measures
Number of participants screened who enroll in trial

PERFORMANCE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Strict SBP TargetExperimental Treatment1 Intervention
Target Systolic Blood Pressure <120 mm Hg
Group II: Usual SBP TargetActive Control1 Intervention
Target Systolic Blood Pressure 130-140 mm Hg

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,503 Previous Clinical Trials
15,236,455 Total Patients Enrolled
Raymond Hsu, MD MASPrincipal InvestigatorUniversity of California, San Francisco
Elaine Ku, MD MASPrincipal InvestigatorUniversity of California, San Francisco
1 Previous Clinical Trials
120 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD
2017. "Pilot to Examine Risk and Feasibility of Remote Management of BP From CKD Through ESRD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02975505.
~46 spots leftby Jul 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top